Cardiovascular Needle Market Share

Cardiovascular Needle Market Overview

Cardiovascular needle Market Size was valued at USD 0.08 Billion in 2023. The Cardiovascular needle industry is projected to grow from USD 0.09 Billion in 2024 to USD 0.16 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.30% during the forecast period (2024 - 2032). 

Cardiovascular needles are used as a part of various heart and vascular mediations to close the surgical wound. Various surgeries such as cardiovascular surgeries, open heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. Rising number of a patient having cardiovascular disease, diabetes, obesity and increasing aging population is driving the market.

According to the World Health Organization (WHO), in 2015, around 17.7 million people died from cardiovascular diseases, which represents 31% of all global deaths. Of these deaths, around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. According to the World Health Organization (WHO) in 2015, around 1.6 million deaths were directly caused by diabetes and in 2014, 8.5% of adults aged 18 years and older had diabetes. Thus, rising prevalence of chronic diseases is majorly driving the global cardiovascular market.

Various factors are adding fuel to the growth of the global market, such as unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the market.

Moreover, advancing technology in the medical devices is adding fuel to the growth of the market. Furthermore, increasing government support in the developing countries drive the cardiovascular needle market growth.

However, increasing use of surgical staples instead of needles and suture can deter the demand for cardiovascular needles.

On 7th March 2024, Hindustan Syringes and Medical Devices (HMD) launched Dispojekt single-use with safety needle, which further which further strengthens India's position in medical devices.

However, on October 13, 2023, Rhythmlink International, LLC, a company that produces medical devices, introduced its new product range called concentric needles. The size of the concentric needle comes in four different forms or gauges with varying lengths and colors depending on how they are used.

As well as an innovative medical device and pharmaceutical packaging company, Sharps Technology Inc., on September 26th, 2023, announced that it had signed an agreement to purchase an asset (APA) with Nephron Pharmaceuticals Corporation, one of the U.S.A’s leading private contract manufacturers for pharmaceuticals under section 503B so as to purchase Nephron’s InjectEZ specialty syringe manufacturing facility. Furthermore, there is also the purchase order from Nephron Pharmaceuticals for over US$400 Mn worth of Next Generation Copolymer Prefillable Syringes Systems.

For instance, BD in July 2022 argued that Investing in Clinical Pharmacists at Community Health Centers Can Significantly Improve Patient Outcomes and advance Health Equity.

SMB Corporation in June 2022 shows Amazing presentations at COMPAMED Innovation Forum: How medical technology fights neurological disorders.

Consequently, Wuxi Biologics started GMP operations at DP5, its new drug product manufacturing site located in Wuxi, China in June this year. The facility offers many different volume delivery options for pre-filled syringes (PFS).

Aesculap, in May 2022, gets exclusive distribution rights to a digital surgical microscope.

B.Braun recently acquired Intermedt Medizin & Technik GmbH, which specializes in the formulation of dialysis concentrates, in March this year (www.bbraun.com).

The other major announcement was made by Medtronic in March 2022, which declared a partnership with Vizient for an AI-powered video management system. This would be an easy way for the Surgical Teams to access procedural videos.

In January 2022, ICU Medical Inc. announced that it had acquired Smiths Medical, a medical device company. Syringe and ambulatory infusion devices, vascular access and vital care products are some of Smiths Medical’s business.

Cardiovascular Needle Market Segment Insights

The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.

Cardiovascular Needle Type Insights

On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles.  

Cardiovascular Needle Market Application Insights

On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.  

Cardiovascular Needle Usage Insights

On the basis of the usage, it is segmented into single use and multiple uses.

Cardiovascular Needle End User Insights

On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Cardiovascular Needle Market Regional Analysis

The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.

Europe holds the second position in the global market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.

The Asia Pacific is the fastest growing market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.

On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.

Cardiovascular Needle Market Key Players

Some of the key the players in the cardiovascular needles market are 

• Becton, Dickinson, and Company (US), 


• B. Braun Melsungen AG (Germany), 


• Sheffield Ltd. (UK), 


• CP Medical, Inc. (the US), 


• Ethicon Inc. (US), 


• KLS Martin Group (US), 


• Sklar Surgical Instruments (US), 


• Rumex International Corporation Ltd. (US), 


• Scanlan International Inc. (US), 


• Teleflex Incorporated (US), 


• Medline Industries, Inc. (US), 


• Surgins surgical Ltd. (UK), 


• Surtex Instruments Ltd. (UK), 


• Cardivon Surgical Inc. (China), 


• Symmetry Surgical Inc. (US), 


• Delacroix-Chevalier (France), 


• Wexler Surgical (US), 


• Quality Needles Pvt. Ltd. (India), 


• FSSB surgical needles GmbH (Germany)

Intended Audience

• Cardiovascular needle manufacturers


• Cardiovascular needle suppliers


• Research and Development (R&D) Companies


• Government Research Laboratories


• Independent Research Laboratories


• Government and Independent Regulatory Authorities


• Market Research and Consulting Service Providers


• Medical Research Laboratories


• Academic Medical Institutes and Universities